205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
2.88%
Revenue growth below 50% of MCHP's 10.00%. Michael Burry would check for competitive disadvantage risks.
-6.26%
Cost reduction while MCHP shows 6.86% growth. Joel Greenblatt would examine competitive advantage.
27.53%
Gross profit growth exceeding 1.5x MCHP's 12.34%. David Dodd would verify competitive advantages.
23.96%
Margin expansion exceeding 1.5x MCHP's 2.13%. David Dodd would verify competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
100.00%
Other expenses growth above 1.5x MCHP's 17.24%. Michael Burry would check for concerning trends.
108.00%
Operating expenses growth above 1.5x MCHP's 7.33%. Michael Burry would check for inefficiency.
144.50%
Total costs growth above 1.5x MCHP's 7.08%. Michael Burry would check for inefficiency.
No Data
No Data available this quarter, please select a different quarter.
100.00%
D&A growth above 1.5x MCHP's 17.24%. Michael Burry would check for excessive investment.
-95.91%
EBITDA decline while MCHP shows 20.18% growth. Joel Greenblatt would examine position.
-96.02%
EBITDA margin decline while MCHP shows 9.25% growth. Joel Greenblatt would examine position.
-95.92%
Operating income decline while MCHP shows 21.18% growth. Joel Greenblatt would examine position.
-96.04%
Operating margin decline while MCHP shows 10.16% growth. Joel Greenblatt would examine position.
100.05%
Other expenses growth while MCHP reduces costs. John Neff would investigate differences.
24.73%
Pre-tax income growth exceeding 1.5x MCHP's 15.91%. David Dodd would verify competitive advantages.
21.24%
Pre-tax margin growth exceeding 1.5x MCHP's 5.37%. David Dodd would verify competitive advantages.
29.67%
Tax expense growth 50-75% of MCHP's 50.00%. Bruce Berkowitz would examine efficiency.
22.34%
Net income growth exceeding 1.5x MCHP's 7.14%. David Dodd would verify competitive advantages.
18.92%
Net margin growth while MCHP declines. John Neff would investigate advantages.
36.36%
EPS growth exceeding 1.5x MCHP's 15.92%. David Dodd would verify competitive advantages.
36.36%
Diluted EPS growth exceeding 1.5x MCHP's 15.92%. David Dodd would verify competitive advantages.
0.19%
Share count increase while MCHP reduces shares. John Neff would investigate differences.
0.28%
Diluted share increase while MCHP reduces shares. John Neff would investigate differences.